For best results when printing this announcement, please click on link below:
RNS Number : 8407V SMBC Nikko Capital Markets Limited 11 April 2023
Date: 11 April 2023
Not for the distribution, directly or indirectly in or into the United States
or any jurisdiction in which such distribution would be unlawful.
Air Products and Chemicals, Inc.
Post - Stabilisation Notice
SMBC Nikko Capital Markets Limited ("SMBC Nikko") (contact: Stephen Apted, +44
20 4507 5017) hereby gives notice, as Stabilisation Coordinator that the
Stabilising Manager(s) named below may stabilise the offer of the following
securities in accordance with Commission Delegated Regulation (EU) 2016/1052
under the Market Abuse Regulation (EU/596/2014) and the UK FCA Stabilisation
Binding Technical Standards.
Issuer: Air Products and Chemicals, Inc.
Guarantor(s) (if any): N/A
Aggregate Nominal Amount: EUR 700,000,000
Description: EUR Notes due March 2035
Senior unsecured, SEC Registered
Governed by New York law
Listing: New York Stock Exchange
Offer price: 99.085 per cent
Stabilising manager: SMBC Nikko Capital Markets Limited, 100 Liverpool Street, London EC2M 2AT
Citigroup Global Markets Limited
HSBC Bank plc
Stabilisation Period started on: 27 February 2023
Stabilisation period last occurred: No stabilisation occurred
This announcement is for information purposes only and does not constitute an
invitation or offer to underwrite, subscribe for or otherwise acquire or
dispose of any securities of the Issuer in any jurisdiction.
This announcement is not for distribution, directly or indirectly, in or into
the United States or any other jurisdiction in which such distribution would
This announcement and the offer of the securities to which it relates are only
addressed to and directed at persons outside the United Kingdom ("UK") and
persons in the UK who have professional experience in matters related to
investments or who are high net worth persons within article 12(5) of the
Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and
must not be acted on or relied on by other persons in the UK.
In addition, if and to the extent that this announcement is communicated in,
or the offer of the securities to which it relates is made in, any EEA Member
State before the publication of a prospectus in relation to the securities
which has been approved by the competent authority in that Member State in
accordance with Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or
which has been approved by a competent authority in another Member State and
notified to the competent authority in that Member State in accordance with
the Prospectus Regulation), this announcement and the offer are only addressed
to and directed at persons in that Member State who are qualified investors
within the meaning of the Prospectus Regulation (or who are other persons to
whom the offer may lawfully be addressed) and must not be acted on or relied
on by other persons in that Member State.
If and to the extent that this announcement is communicated in, or the offer
of the securities to which it relates is made in, the UK before the
publication of a prospectus in relation to the securities which has been
approved by the competent authority in the UK in accordance with the
Prospectus Regulation, as it forms part of domestic law by virtue of the
European Union Withdrawal Act 2018 (the "UK Prospectus Regulation"), this
announcement and the offer are only addressed to and directed at persons in
the UK who are qualified investors within the meaning of the UK Prospectus
Regulation (or who are other persons to whom the offer may lawfully be
addressed) and must not be acted on or relied on by other persons in the UK.
Singapore SFA Product Classification: The Issuer has determined, and hereby
notifies all relevant persons (as defined in Section 309A(1) of the Securities
and Futures Act (Chapter 289 of Singapore) (the "SFA"), that the securities
are 'prescribed capital markets products' (as defined in the Securities and
Futures (Capital Markets Products) Regulations 2018).
This communication does not constitute any offering of the securities
referenced or any securities in Japan. The securities referenced have not been
and will not be registered under the Financial Instruments and Exchange Act of
Japan (Act No. 25 of 1948, as amended, the "FIEA") and, accordingly, such
securities referenced will not be offered or sold directly or indirectly, in
Japan or to, or for the benefit of, any resident of Japan or to others for
re-offering or resale, directly or indirectly, in Japan or to any resident of
Japan except pursuant to an exemption from the registration requirements of,
and otherwise in compliance with the FIEA and other relevant laws and
regulations of Japan. As used in this paragraph, "resident of Japan" means any
person resident in Japan, including any corporation or other entity organised
under the laws of Japan.
This announcement is not an offer of securities for sale into the United
States. The securities have not been, and will not be, registered under the
United States Securities Act of 1933 and may not be offered or sold in the
United States absent registration or an exemption from registration. There
will be no public offer of securities in the United States.
ANY DISCLAIMER OR OTHER NOTICE THAT MAY APPEAR BELOW IS NOT APPLICABLE TO THIS
COMMUNICATION AND SHOULD BE DISREGARDED. SUCH DISCLAIMER OR NOTICE WAS
AUTOMATICALLY GENERATED AS A RESULT OF THIS COMMUNICATION BEING SENT BY
BLOOMBERG OR ANOTHER EMAIL SYSTEM.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
. END STAEAFLFFEPDEFA